Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Forst

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Clinical Chemistry and Laboratory Medicine|March 17, 2009
Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the testsMichael Safinowski, Birgit Wilhelm, Tanja Reimer, et al.
Diabetes Technology & Therapeutics|August 21, 2007
Peripheral leptin levels in narcoleptic patientsNorbert Dahmen, Alice Engel, Jana Helfrich, et al.
Journal of Diabetes Science and Technology|November 4, 2009
The beta-specific protein kinase C inhibitor ruboxistaurin (LY333531) suppresses glucose-induced adhesion of human monocytes to endothelial cells in vitroThomas Kunt, Thomas Forst, Christof Kazda, et al.
Diabetes Technology & Therapeutics|May 14, 2008
The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditionsEfstrathios Karagiannis, Andreas Pfützner, Thomas Forst, et al.
Diabetes Care|February 28, 2004
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetesAndreas Pfützner, Thomas Kunt, Cloth Hohberg, et al.
Clinical Laboratory|October 16, 2004
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistanceAndreas Pfützner, Peter H Kann, Anke H Pfützner, et al.
Expert Opinion on Medical Diagnostics|October 4, 2013
The precision study: examining the inter- and intra-assay variability of replicate measurements of BGStar, iBGStar and 12 other blood glucose monitorsSanja Ramljak, Petra B Musholt, Christina Schipper, et al.
Molecular Diagnosis & Therapy|April 9, 2009
Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter geneMoritz Eidens, Alexander Weise, Stefan Prause, et al.
Journal of Diabetes Science and Technology|December 20, 2013
Blood glucose meters employing dynamic electrochemistry are stable against hematocrit interference in a laboratory settingAndreas Pfützner, Petra B Musholt, Christina Schipper, et al.
Journal of Diabetes Science and Technology|March 10, 2012
Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitusThomas Forst, Matthias M Weber, Michael Mitry, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Clinical Chemistry and Laboratory Medicine|March 17, 2009
Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the testsMichael Safinowski, Birgit Wilhelm, Tanja Reimer, et al.
Diabetes Technology & Therapeutics|August 21, 2007
Peripheral leptin levels in narcoleptic patientsNorbert Dahmen, Alice Engel, Jana Helfrich, et al.
Journal of Diabetes Science and Technology|November 4, 2009
The beta-specific protein kinase C inhibitor ruboxistaurin (LY333531) suppresses glucose-induced adhesion of human monocytes to endothelial cells in vitroThomas Kunt, Thomas Forst, Christof Kazda, et al.
Diabetes Technology & Therapeutics|May 14, 2008
The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditionsEfstrathios Karagiannis, Andreas Pfützner, Thomas Forst, et al.
Diabetes Care|February 28, 2004
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetesAndreas Pfützner, Thomas Kunt, Cloth Hohberg, et al.
Clinical Laboratory|October 16, 2004
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistanceAndreas Pfützner, Peter H Kann, Anke H Pfützner, et al.
Expert Opinion on Medical Diagnostics|October 4, 2013
The precision study: examining the inter- and intra-assay variability of replicate measurements of BGStar, iBGStar and 12 other blood glucose monitorsSanja Ramljak, Petra B Musholt, Christina Schipper, et al.
Molecular Diagnosis & Therapy|April 9, 2009
Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter geneMoritz Eidens, Alexander Weise, Stefan Prause, et al.
Journal of Diabetes Science and Technology|December 20, 2013
Blood glucose meters employing dynamic electrochemistry are stable against hematocrit interference in a laboratory settingAndreas Pfützner, Petra B Musholt, Christina Schipper, et al.
Journal of Diabetes Science and Technology|March 10, 2012
Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitusThomas Forst, Matthias M Weber, Michael Mitry, et al.
Pageof 15